glp-1 agonist alzheimer's Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus Repurposing glucagon-like peptide-1 receptor agonists

Analyses of medical records for people with diabetes or obesity have found a lower risk of AUD among those treated with a GLP-1

, Cappelen, K

doi:10.1210/jcem-24-10-1076 181

To connect with experts from Stony Brook Medicines Bariatric and Metabolic Weight Loss Center, visit our website or call (631) 444-2274.

This would be in line with a recent propensity-score matched cohort study by our laboratory, which observed that semaglutide was associated with reduced cognitive deficit and nicotine misuse when compared against three other antidiabetic medications 227

You might need to switch because of side effects, insurance coverage, treatment goals, or another reason